BC’s most promising new healthtech companies kick off Hypergrowth program
Summary
HeadCheck Health, Navigate Surgical Technologies (NST), and ViewsIQ have been selected by Genome British Columbia and the BC Tech Association to take part in the first-ever HyperGrowth: Life accelerator program cohort. “The selection process was not easy, but the quality of the applications and the strength of the cohort exemplify the future of B.C.’s bioeconomy,” said Dr. Pascal Spothelfer, president and CEO of Genome BC. Going forward, these startups will be part of a 12-month program including workshops, mentorship, and support from organizations like Accel-Rx, the Centre for Drug Research and Development (CDRD), entrepreneurship@UBC, InterfaceHealth, SFU Innovates, TELUS Health, and Wavefront. “We have a product that our customers tell us they love and we are now setting the company up for growth.” The healthtech sector is getting new traction thanks to increased willingness from large health institutions to try to innovate in how they deliver services, said Dylan Freeze, a program manager with the BC Tech Association. “The situation is changing because health organizations here are becoming more proactive in using these early-stage companies’ technologies in pilot programs, which can lead to bigger things,” Freeze explained.